Time to SGLT2 inhibitors initiation in patients with heart failure

No abstract available.

Information

Citation

Moon J, Udell JA, Chong A, Fang J, Austin PC, Ko DT, Stukel TA, Atzema CL, Booth GL, Tu K, Naimark DMJ, Jackevicius CA. J Am Heart Assoc. 2024; Apr 2 [Epub ahead of print].

View Source

Contributing ICES Scientists

Discover More

Journal Article

24/09/2025

The impact of semaglutide on peri-operative cardiovascular outcomes in diabetes

Castrillon F, Carter B, McClure A, Welk B, Clemens KK. Diabetes Obes Metab. 2025 Sep 24 [Epub ahead of print].

Journal Article

24/09/2025

Trends in health care services use and mortality in adults with cardiometabolic diseases during the first year of the pandemic in Ontario, Canada

Kendzerska T, Saymeh M, Pugliese M, Povitz M, Robinson B, Edwards JD, To T, Gershon A. Circ Cardiovasc Qual Outcomes. 2025; e011996. Epub 2025 Sep 24.

Journal Article

16/09/2025

Sex differences in access to physician care following a new diagnosis of heart failure in the ambulatory setting

Lee JG, Lee F, Pugliese M, Mielniczuk LM, Sun LY. Can J Cardiol. 2025; 16:S0828-282X(25)01164-X. Epub 2025 Sep 16.

See All

Time to SGLT2 inhibitors initiation in patients with heart failure

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Topics

Associated Sites

Discover More

The impact of semaglutide on peri-operative cardiovascular outcomes in diabetes

Trends in health care services use and mortality in adults with cardiometabolic diseases during the first year of the pandemic in Ontario, Canada

Sex differences in access to physician care following a new diagnosis of heart failure in the ambulatory setting